ROCKWELL MEDICAL, INC. Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31)
ROCKWELL MEDICAL, INC. (RMTI) had Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31) of $27.04 thousand as of 2012-09-30, per its 10-Q filed 2012-11-09.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGainLoss · last filed 2012-11-09
- 2012-09-30: Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31) $27.04K.
- 2011-09-30: Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31) $362.67K.
| Period end | Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31) |
|---|---|
| 2012-09-30 | $27.04K 10-Q · filed 2012-11-09 |
| 2011-09-30 | $362.67K 10-Q · filed 2012-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |